Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised Phase II study of oral versus intravenous vinorelbine in metastatic breast cancer after anthracyclines
2004-000963-81Phase 2Completed
- Sponsor
- Robapharm
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of vinorelbine in breast cancer (2 arms), sponsored by Robapharm. Primary endpoints: Tumor response with oral vinorelbine and Tumor response with intravenous vinorelbine. Started Nov 2004; status: completed.
02
Drugs
vinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-000963-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000963-81.